Clinical trial
A Pilot Study of Combined Chemotherapy and Donor Lymphocyte Infusion for Hematologic Malignancies in Relapse After Allogeneic Bone Marrow Transplantation
NCT00005946 is registered in ClinicalTrials.gov with University of Maryland, Baltimore as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Study of Combined Chemotherapy and Donor Lymphocyte Infusion for Hematologic Malignancies in Relapse After Allogeneic Bone Marrow Transplantation
- Lead sponsor
- University of Maryland, Baltimore
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- October 31, 2000
- Completion date
- June 30, 2002
- Enrollment
- Not reported
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
leukemia, lymphoma, multiple myeloma and plasma cell neoplasm, myelodysplastic syndromes